Advertisement
Canada markets open in 2 hours 1 minute

  • S&P/TSX

    22,244.02
    +20.35 (+0.09%)
     

  • S&P 500

    5,537.02
    +28.01 (+0.51%)
     

  • DOW

    39,308.00
    -23.90 (-0.06%)
     

  • CAD/USD

    0.7347
    +0.0000 (+0.00%)
     

  • CRUDE OIL

    83.85
    -0.03 (-0.04%)
     

  • Bitcoin CAD

    75,190.14
    -3,364.55 (-4.28%)
     

  • CMC Crypto 200

    1,149.78
    -58.91 (-4.88%)
     

  • GOLD FUTURES

    2,372.30
    +2.90 (+0.12%)
     

  • RUSSELL 2000

    2,036.62
    +2.75 (+0.14%)
     

  • 10-Yr Bond

    4.3550
    0.0000 (0.00%)
     

  • NASDAQ futures

    20,443.75
    +32.25 (+0.16%)
     

  • VOLATILITY

    12.45
    +0.19 (+1.55%)
     

  • FTSE

    8,246.05
    +4.79 (+0.06%)
     

  • NIKKEI 225

    40,912.37
    -1.28 (-0.00%)
     

  • CAD/EUR

    0.6786
    -0.0006 (-0.09%)
     

Compared to Estimates, Clarivate PLC (CLVT) Q3 Earnings: A Look at Key Metrics

Zacks Equity Research
·2 min read

Clarivate PLC (CLVT) reported $647.2 million in revenue for the quarter ended September 2023, representing a year-over-year increase of 1.8%. EPS of $0.21 for the same period compares to $0.20 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $631.35 million, representing a surprise of +2.51%. The company delivered an EPS surprise of +16.67%, with the consensus EPS estimate being $0.18.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

ADVERTISEMENT

Here is how Clarivate PLC performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenue- Intellectual Property: $211.70 million versus the four-analyst average estimate of $210.74 million.

  • Revenue- Life Sciences and Healthcare: $108.30 million versus $104.34 million estimated by four analysts on average.

  • Revenue- Academia and Government: $327.20 million compared to the $321.21 million average estimate based on four analysts.

  • Revenue- Transactional Revenue: $132.30 million versus the two-analyst average estimate of $108.21 million. The reported number represents a year-over-year change of +5.8%.

  • Revenue- Re-occurring revenues: $106.80 million versus $107.33 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +4% change.

  • Revenue- Subscription Revenue: $408.10 million compared to the $420.50 million average estimate based on two analysts. The reported number represents a change of -0.1% year over year.

View all Key Company Metrics for Clarivate PLC here>>>

Shares of Clarivate PLC have returned +6% over the past month versus the Zacks S&P 500 composite's +1.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Clarivate PLC (CLVT) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research